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ABSTRACT
Introduction: Inspiratory muscle weakness is a known
consequence of mechanical ventilation and a potential
contributor to difﬁculty in weaning from ventilatory
support. Inspiratory muscle training (IMT) reduces the
weaning period and increases the likelihood of
successful weaning in some patients. However, it is not
known how this training affects the residual inspiratory
muscle fatigability following successful weaning nor
patients’ quality of life or functional outcomes.
Methods and analysis: This dual centre study
includes two concurrent randomised controlled trials
of IMT in adult patients who are either currently
ventilator-dependent (>7 days) (n¼70) or have been
recently weaned from mechanical ventilation
(>7 days) in the past week (n¼70). Subjects will be
stable, alert and able to actively participate and provide
consent. There will be concealed allocation to either
treatment (IMT) or usual physiotherapy (including
deep breathing exercises without a resistance device).
Primary outcomes are inspiratory muscle fatigue
resistance and maximum inspiratory pressures.
Secondary outcomes are quality of life (Short Form-
36v2, EQ-5D), functional status (Acute Care Index of
Function), rate of perceived exertion (Borg Scale),
intensive care length of stay (days), post intensive care
length of stay (days), rate of reintubation (%) and
duration of ventilation (days).
Ethics and dissemination: Ethics approval has been
obtained from relevant institutions, and results will be
published with a view to inﬂuencing physiotherapy
practice in the management of long-term ventilator-
dependent patients to accelerate weaning and optimise
rehabilitation outcomes.
Trial registration number: ACTRN12610001089022.
BACKGROUND
Mechanical ventilation (MV) used in inten-
sive care units (ICUs), while often essential in
the management of respiratory failure, can
result in respiratory dysfunction and inspira-
tory muscle weakness.
1 Even patients who can
successfully wean from MV may suffer
impaired fatigue resistance of the inspiratory
muscles following successful weaning.
2
Inspiratory muscle weakness has been asso-
ciated with difﬁculty weaning from MV,
3 and
the degree of weakness is correlated with the
duration of ventilation.
23One caseecontrol
study demonstrated that MV results in
increased proteolysis and atrophy in the dia-
phragm muscle, while other skeletal muscles
are spared.
4 Clearly, inspiratory muscle
weakness is likely to be at least one of the
factors that could contribute to difﬁcult and
prolonged weaning from MV.
5
Inspiratory muscle training (IMT) with
a threshold device has been used in patients
with chronic lung disease for many years,
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ARTICLE SUMMARY
Article focus
- Mechanical ventilation (MV) is known to cause
inspiratory muscle weakness, which may
contribute to both difﬁculty weaning and poor
recovery.
- Can IMT hasten weaning and enhance recovery
from MV if commenced while still ventilated?
- Can IMT enhance recovery if commenced
following weaning from MV?
Key messages
- This protocol outlines two concurrent rando-
mised controlled trials that investigate the effects
of IMT as a component of early rehabilitation in
an Australian intensive care unit.
- The study is designed to capture both physio-
logical measures as well as patient-centred
measures of function and quality of life.
Strengths and limitations of this study
- This study is the ﬁrst of its kind to focus on
patient-centred measures and longer term
outcomes beyond the period of ventilatory
weaning.
- The results of this study will not be generalisable
to some intensive care units, which generally
keep patients sedated, as patient alertness is
a requirement of IMT.
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Open Access Protocolresulting in not just increased inspiratory muscle strength
but also increased inspiratory muscle endurance, reduced
dyspnoea and increased exercise tolerance and quality of
life.
6 Since 2002, case reports of IMT in ventilator-
dependent patients have suggested that IMT is associated
with favourable weaning outcomes.
7e9 More recently, two
randomised trials
10 11 using different training strategies
have demonstrated beneﬁts of IMT for ventilated patients,
including statistically signiﬁcant increases in inspiratory
muscle strength,
10 11 reduced weaning time by a mean of
1.7 days
10 and a higher rate of successful weaning at day
28 (71% compared to 47%).
11 However, the general-
isability of these results is limited by the subgroups studied
(aged older than 70 years,
10 failed to wean
11)a sw e l la st h e
sedation and rehabilitation approaches used in the
investigating centres units. It is not yet known whether
similar results would apply to a more heterogeneous
group of ICU patients in an Australian ICU context. For
example, an approach of minimal sedation and early
active rehabilitation may result in different training effects
and relative beneﬁts of IMT. It is also not known which
training parameters are optimal.
In an analysis of 195 IMT treatments in ventilated
patients, IMT was found to be safe with zero adverse
outcomes and stable physiological parameters in
response to training (blood pressure, heart rate, oxygen
saturation and respiratory rate).
12 However, the mecha-
nisms of improvement with IMT in ventilated patients
have not been investigated. It is theoretically feasible
that a high-intensity training protocol could provide an
adequate training stimulus to halt or reverse diaphrag-
matic atrophy and proteolysis.
4 As has been shown in
athletes, IMT could also attenuate a sympathetically
mediated metaboreﬂex, resulting in enhanced limb
muscle perfusion.
13 This improved limb perfusion could
facilitate early mobilisation, resulting in enhanced
functional capacity or quality of life.
The following protocol outlines the process by which
we intend to answer some of these questions with regard
to IMT in a heterogeneous group of patients who have
been ventilator-dependent for 7 days or longer in our
Australian ICU setting. The protocol describes two
separate but concurrent studies:
1. A randomised trial of patients who commence IMT
while still ventilated (randomised controlled trial 1
(RCT1)).
2. A randomised trial of patients who could not
participate actively while ventilated but commence
IMT within 1 week of successfully weaning from MV
(randomised controlled trial 2 (RCT2)).
For clarity in this protocol, ‘the study’ refers to both
RCT1 and RCT2 combined. Where RCT1 and RCT2
differ, this will be described explicitly.
RCT1: OVERVIEW
This trial (RCT1) examines the effects of IMT on post-
weaning outcomes for patients who undergo MV for at
least 7 days and commence training while ventilator-
dependent. This trial was registered with the Australia
New Zealand Clinical Trials Registry on 13 December
2010 (ACTRN12610001089022).
Aims
RCT1 aims to answer the following questions:
1. Does IMT, commenced while mechanically ventilated,
affect the fatigability of respiratory muscles following
weaning from prolonged MV (>7 days)?
2. Does IMT, commenced while mechanically ventilated,
affect the duration of ventilation required or the rate
of reintubation in these patients?
3. Is there a measurable difference in the stress response
and/or anabolic response in patients undergoing
IMT compared to routine physiotherapy?
4. Does IMTaffect dyspnoea, quality of life or functional
measures or post-ICU length of hospital stay following
successful ventilatory weaning?
Hypotheses
The hypotheses are that IMT will reduce inspiratory
muscle fatigability, dyspnoea and possibly duration of
ventilation and post-ICU length of hospital stay and will
improve quality of life and functional measures in this
population without concomitant increases in the stress
response or detectable changes in muscle anabolism.
Methods
Two RCTs will be conducted concurrently at two sites,
with the anticipated ﬂow of patients described in
ﬁgure 1. Randomisation for the study will be provided
through a computer-generated random number
sequence, managed off-site by clerical staff unconnected
with the study and accessible to the investigators only via
telephone to ensure concealed allocation. All ICU
patients will be screened daily for study eligibility by the
senior ICU physiotherapist. Eligible participants will be
invited to participate and subsequently enrolled by the
chief investigator, and baseline measures completed
prior to allocation.
A total of 70 subjects will be required for RCT1. On the
basis of data extrapolated from previous case series, this
provides a power estimate for expected differences in
fatigue resistance indices (FRI) between the groups of
0.8, if a¼0.05. Sample sizes have been inﬂated 15% to
account for the known mortality of this patient popula-
tion (12.8%) (Canberra Hospital ICU Audit data 2009).
Subjects
Subjects will be recruited from both Canberra Hospital
ICU and Calvary Hospital ICU (both located in
Canberra, Australia). Patients mechanically ventilated
for more than 7 days who are alert and able to co-operate
with training (Riker SedationeAgitation Score
14 of 4)
and can provide informed consent will be randomised
(computer-generated random number sequence,
concealed allocation) to receive either IMT or usual
physiotherapy care. Usual physiotherapy care typically
involves deep breathing exercises (without a resistance
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Protocol: inspiratory muscle training for ventilated patients (RCT)device), manual hyperinﬂation,
15 secretion clearance
techniques, assisted mobilisation
16 17 and upper and
lower limb exercise as indicated.
Inclusion criteria
All patients admitted to ICU who:
< are mechanically ventilated through invasive means
for 7 days or longer;
< are aged $16 years;
< are alert and able to co-operate with training (Riker
score of 4);
< are able to provide informed consent;
< are haemodynamically stable and requiring minimal
ventilatory support (ie, positive end expiratory pres-
sure (PEEP) #10).
Exclusion criteria
Patients will be excluded from RCT1 if they are:
< undergoing non-invasive ventilation only;
< aged <16 years;
< unwilling to consent or not able to provide informed
consent;
< previously included in RCT1 (ie, patients readmitted
to ICU);
< pregnant;
< mechanically ventilated <7 days;
< not alert or able to co-operate with training (Riker
score of <4o r>4);
< requiring high levels of ventilatory support (eg, PEEP
>10 cmH2O, FiO2 >0.60, nitric oxide, nebulised
prostacyclin, high frequency oscillation) and/or
where the treating team (medical and/or physio-
therapy) deems risks of brief disconnection from
ventilation unacceptable;
< medically unstable (eg, new cardiac arrhythmia,
acutely septic) where the treating team (medical
and/or physiotherapy) considers that interference
with ventilatory support could compromise patient’s
recovery and/or are deemed suitable for palliation;
< experiencing signiﬁcant pain that interferes with
breathing capacity (eg, fractured ribs): IMT could
be reconsidered when pain is controlled and patient
is able to participate.
Outcome measures
Table 1 provides a summary of the outcome measures
used in RCT1.
Interventions, samples and assays
Muscle trainer
IMT will be performed using the Threshold IMT inspi-
ratory muscle trainer (Threshold IMT device HS730;
Respironics, Parsippany, New Jersey, USA). This device
has been validated in both healthy patients and those
with chronic lung disease
18 and is superior to alternative
ﬂow resistance devices due to its reliability in ensuring
prescribed pressures are achieved regardless of subject’s
ﬂow rate.
18
The training parameters are based on previously
published case studies
7e9 and are consistent with
evidence-based IMT training guidelines in patients with
chronic lung disease,
19 which recommend that high-
intensity interval training is well tolerated and optimises
outcomes.
20 The physiotherapist prescribes the highest
tolerable intensity that allows the subject to just
complete the sixth breath in a set of six breaths.
11 The
intensity is gradually increased by the physiotherapist
across the training period to provide adequate training
stimulus. Training is performed daily on weekdays, with
the physiotherapist assisting the patient to perform ﬁve
sets of six breaths each session. Between sets, patients are
Figure 1 Flow of participants
through the study. FRI, fatigue
resistance index; IMT, inspiratory
muscle training; MIP, maximum
inspiratory pressure; QOL, quality
of life; RCT, randomised
controlled trial; RPE, rate of
perceived exertion.
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(typically <60 s). The whole training session takes
<10 min per day. Training will be provided by the chief
investigator, senior ICU physiotherapist or a physio-
therapy department staff member who has been trained
and credentialed in the technique in accordance with
our previously published protocol.
9
Respiratory strength and fatigue measurement
Inspiratory muscle strength will be measured as maximum
inspiratory pressure (MIP), in accordance with the
protocol described by the American Thoracic Society and
European Respiratory Society.
21 Brieﬂy, this technique
requires the patient to maximally inhale from residual
volume into a handheld pressure manometer and sustain
the effort for more than 1 s. Noseclips are not required.
The patient is coached to ensure adequate lip seal around
the mouth piece and achieve maximum voluntary effort,
and the effort is repeated until at least three measure-
ments have <20% variability between them.
21
The device used to perform MIP testing is a portable
MicroRPM Respiratory Pressure meter (CareFusion, San
Diego, CA, USA) (Australian Therapeutic Goods Adm-
inistration approval 166760). Such handheld devices
have demonstrated reliability and validity
22 and are easy
to use at the bedside in ICU or ward environments. The
device will be zeroed and calibrated before each
measurement.
The method of determining fatigue resistance
capacity is the protocol used by Chang and colleagues
2
and is based on the maximum incremental threshold
loading test described in the American Thoracic
Society/European Respiratory Society guidelines.
23
Following successful weaning from MV (ie, within
24e48 h), the patients’ FRI is calculated. Following
three MIP measurements (as above), subjects breathe
through inspiratory resistance (through the Threshold
IMT device) equivalent to 30% of the initial MIP for
2 min. This level of resistance that has been selected as
the preliminary trials by Chang and colleagues
2 indi-
cated that resistance equivalent to 50% of MIP resulted
in severe dyspnoea. If the subject is not able to inspire at
30% of their MIP, no resistance is applied. MIP
measurements are repeated at 2 min. During the
loading task, the testing will be ceased if the rate of
perceived exertion (RPE) is $7, pulse oximetric satu-
ration falls >10% from initial values or to <90% or the
heart rate increases by >30 beats per minute. FRI is
calculated comparing the preloading and postloading
values of the MIP (ie, post-MIP/pre-MIP). The FRI
procedure is repeated 7 days after successful weaning
from ventilation.
Cortisol and urea sampling
Patients with an indwelling catheter in situ will have 24 h
urine at baseline and day 7. Urine will be assayed for
cortisol, creatinine and urea using high performance
liquid chromatography.
Dyspnoea (shortness of breath)
Dyspnoea will be measured using a Modiﬁed Borg Scale
(RPE categorical score out of 10), which has been found
to have acceptable reliability and validity in patients
undergoing MV.
24 RPE will be recorded both at rest and
during exercise at successful weaning (24 h) and 1 week
postweaning (by a blinded assessor).
Table 1 Outcome measures used in the study
Outcome measure RCT1 RCT2
Fatigue resistance index (primary
outcome measure)
24 h postweaning; 7 days postweaning Commencement of training;
day 14 of training
Maximum inspiratory pressure Commencement of training; 24 h
postweaning; 7 days postweaning
Commencement of training;
day 14 of training
Quality of life/functional assessments
(Short Form-36, EQ-5D, Acute Care
Index of Function)
Commencement of training; 7 days
postweaning
Commencement of training;
day 14 of training
Rate of perceived exertion at rest and
during training
Commencement of training; 7 days
postweaning
Commencement of training;
day 14 of training
Duration of mechanical ventilation (days)
and duration of weaning (from commencement
of pressure-support only to 24 h ventilator-free)
U NA
ICU length of stay (days) U NA
Post-ICU discharge length of hospital stay
(days) and hospital discharge destination
(including in-hospital mortality)
UU
ICU readmission rates and reintubation
rates (%)ddeﬁned as reintubation required
within 48 h of extubation
UU
Urinary cortisol, creatinine and urea levels Commencement of training; day 7
of training
NA
ICU, intensive care unit; NA, not applicable; RCT, randomised controlled trial.
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Quality of life is measured using the Short Form-36v2
tool (acute 1 week time frame) and the EQ-5D tool as
one combined survey. The Short Form-36 tool has
demonstrated reliability, responsiveness, construct and
criterion validity and is responsive to clinical improve-
ment in an ICU population.
25 The EQ-5D tool has also
been used in intensive care patient follow-up
26 and is
likely to give a more global measure of health-related
quality of life. The survey will be completed on enrol-
ment and 7 days following successful weaning.
Functional level will be measured using the Acute Care
Index of Function (ACIF), which has good levels of inter-
rater reliability
27 and construct validity
28 in acute neuro-
logical conditions, however, has not been examined
speciﬁcally in the ICU population. There are unpub-
lished reports of the ACIF being used to measure
functional recovery in ventilated patients and other non-
neurological acute conditions.
29 In the absence of a more
speciﬁc tool that has been validated for ICU patients, the
construct validity of the ACIF renders it the most useful
tool to measure functional recovery in this study.
RCT2: OVERVIEW
This trial (RCT2) examines the effects of IMT on
outcomes for patients who, for whatever reason, were
unable to participate in IMT while still ventilator-
dependent but have since weaned from ventilation
within the previous 7 days and are now able to partici-
pate in training (eg, due to resolution of acute delirium,
return of cardiovascular stability, etc). The outcomes of
this trial will be analysed in relation to the ﬁndings of
Chang and colleagues
2 that prolonged MV results in
increased fatigability of inspiratory muscles following
successful weaning from MV. Given that postweaning
outcomes are often poor for patients undergoing
prolonged MV,
30 evaluation of IMT as a method to
ameliorate residual weakness, and thus accelerate reha-
bilitation, appears warranted. This trial was registered
with the Australia New Zealand Clinical Trials Registry
on 13 December 2010 (ACTRN12610001089022).
Aims
RCT2 aims to answer the following questions:
1. Does postweaning IMT affect residual inspiratory
muscle strength or fatigability in patients ventilated
for 7 days or longer?
2. Does postweaning IMT affect dyspnoea levels, quality
of life or functional recovery in patients ventilated for
7 days or longer?
3. Does postweaning IMT result in lower rates of
reintubation, readmission to ICU or duration of
post-ICU hospital stay, in patients who have been
ventilated for 7 days or longer?
Hypotheses
The hypotheses are that postweaning IMT will improve
inspiratory muscle strength, reduce inspiratory muscle
fatigability and dyspnoea and improve quality of life and
functional measures in this population. Furthermore, it
is hypothesised that IMT will result in a lower rate of
reintubation and shorter post-ICU length of hospital stay
in these patients.
Methods
RCT2 is a RCT with concealed allocation, blinded
outcome assessors and intention-to-treat analysis. Refer
to the second arm of ﬁgure 1 regarding anticipated ﬂow
of patients through RCT2.
Subjects
Subjects will be recruited from both Canberra Hospital
and Calvary Hospital ICUs (both in Canberra, Australia).
Patients who have recently weaned from MV in ICU
(within previous 7 days, where the duration of ventila-
tion was 7 or more days) will be recruited to RCT2, with
automatic exclusion of patients included in RCT1. Suit-
able patients will be randomised (computer-generated
randomisation sequence) to receive either IMT (in
addition to usual physiotherapy care) or usual physio-
therapy care only for 2 weeks postweaning. Usual phys-
iotherapy care typically includes deep breathing
exercises
31 (without a resistance device), assisted mobi-
lisation,
32 secretion clearance techniques and upper and
lower limb exercises as indicated. Treatment will occur in
both ICU and ward environments.
A total of 70 subjects will be required for RCT2. On the
basis of data extrapolated from previous case series, this
provides a power estimate for expected differences in
FRI between the groups of 0.8, if a¼0.05. Again, sample
sizes have been inﬂated 15% to account for the known
mortality of this population (12.8%) (Canberra Hospital
ICU Audit data 2009).
Inclusion criteria
All patients recently mechanically ventilated who:
< were ventilated for 7 days or longer and weaned from
MV in the previous 7 days;
< are aged $16 years;
< are alert and able to co-operate with training (Riker
score of 4);
< are able to provide informed consent.
Exclusion criteria
Patients will be excluded from RCT2 if they are:
< aged<16 years;
< unwilling or unable to provide informed consent;
< previously included in RCT1;
< pregnant;
< mechanically ventilated <7 days;
< not alert or able to co-operate with training (Riker
score of <4o r>4);
< experiencing signiﬁcant pain that interferes with
breathing capacity (eg, fractured ribs): IMT could
be reconsidered when pain is controlled and patient
is able to participate;
< medically unstable or deemed suitable for palliation.
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Table 1 provides a summary of the outcome measures
used in RCT2.
Interventions, samples and assays
Refer to RCT1 for details of the Threshold IMT device
and training parameters. The only difference for RCT2 is
that there will be no return to MV between sets, rather
the patient is rested (either on room air or oxygen) as
appropriate. As per the previous description, the
training session will be directly supervised by the phys-
iotherapist and should take <10 min/day. Training will
occur on weekdays from enrolment until 2 weeks later.
All other outcome measures will be conducted as previ-
ously described in the time frames outlined in table 1.
TERMINATION CRITERIA
An individual would be withdrawn from the study in the
case of death, withdrawal of consent or ability to partic-
ipate actively. Should a patient in the view of the treating
physician not tolerate the intervention, for whatever
reason, the patient may be withdrawn from the study;
however, follow-up data including FRI would still be
collected and all data collected will be analysed on an
intention-to-treat basis. Adverse outcomes are not antic-
ipated, due to the demonstrated safety of the technique
in our own pilot data
12 and the lack of documented
adverse sequelae in other studies.
7 8 10 11
According to a recent multisite study on the safety of
physiotherapy intervention in ICU,
33 the following
criteria would cause the treating therapist to cease the
intervention immediately and alert on-site medical
attention (ie, senior ICU registrar): alteration in blood
pressure > or <20% resting, alteration in heart rate
< or >20% resting, new arrhythmia, oxygen desatu-
ration >10%, pulmonary artery pressure (systolic)
>60 mm Hg, suspected pneumothorax and agitation
risking detachment of equipment or lines or requiring
increase sedation. Should such an episode occur, the
participant’s suitability for remaining in the trial would
be reviewed by the chief investigator, in consultation with
senior ICU medical staff.
MINIMISING BIAS
Outcome measures will be taken by blinded assessors;
however, therapists providing the intervention cannot be
blinded.
Patients will be informed that the study is investigating
different types of ‘breathing exercises’, without refer-
ence to a device, thus allowing blinding of the patients.
Although a sham comparison would be ideal, most sham
interventions with the threshold device have used low
training pressures (eg, 9e11 cmH2O). The concern is
that for the weakest patients, this level of training can be
challenging. In our pilot case series,
12 several subjects
trained for several sessions with pressures below
15 cmH2O pressure, generating RPE scores of >7. Our
observations are also substantiated by the work of De
Jonghe et al
3 who were able to quantify the median MIP
for ventilated patients who have returned to conscious-
ness as only 30 cmH2O. That is, a mere 9 cmH2O
training pressure would equate to 30% of MIP, and 30%
intensity has shown training beneﬁts in patients with
chronic obstructive pulmonary disease (COPD).
34e36
Thus, it would be difﬁcult to use a true sham without
risking inadvertent ‘training’ of the weakest patients. As
an alternative to a true ‘sham’ comparison, the control
subjects will receive daily coached breathing exercises
(deep breathing or demand ventilation exercises without
a threshold device) to minimise the potential
Hawthorne effect.
PROPOSED METHODS OF DATA ANALYSIS
Data will be analysed using both an intention-to-treat
and per-protocol analysis with a carry forward analysis for
missing data. Mean changes scores, SDs and 95% CIs will
be calculated between groups for preintervention and
postintervention. It is anticipated that the analysis will
use a combination of t tests, c
2 tests and repeated
measures analysis of variance (or non-parametric equiv-
alents) as appropriate. If missing data is a problem,
a mixed model may be used. There will be a baseline
comparison of age, gender, Acute Physiology and
Chronic Health Evaluation II (APACHE II) scores,
highest Sequential Organ Failure Assessment (SOFA)
score and length of stay. There will be a priori stratiﬁ-
cation of those subjects with known neuromuscular
disease (eg, GuillaineBarre, motor neuron disease,
myasthenia gravis).
Predictive modelling
A substudy of RCT1 will analyse the correlation between
IMT pressures (cmH2O) and duration of weaning
(hours off ventilator in a 24 h period). If possible
a mathematical model linking these two variables will be
described.
Contingencies
Should subject recruitment prove slow to reach the
required sample size for this study, the study duration
may be increased by 6e12 months as required, pending
ongoing ethics approval.
Data management
A custom-designed database will store deidentiﬁed
patient data in a secure password-protected ﬁle acces-
sible only to designated research ofﬁce staff. Data will be
entered by blinded research ofﬁce staff from hard
copies, which are stored in a locked ofﬁce. Data
completeness will be reviewed by research ofﬁce staff
quarterly and cross-referenced with existing medical
records. The investigators will only have access to the
database on completion of the study.
CONCOMITANT INTERVENTIONS
All usual physiotherapy interventions, including early
mobilisation as is the standard of care in both ICUs, will
be allowed.
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Protocol: inspiratory muscle training for ventilated patients (RCT)No speciﬁc medical or surgical interventions are
disallowed for trial participants other than those
described in the exclusion criteria above.
ETHICS AND DISSEMINATION
Ethics approval has been gained for these studies
through three institutional committees:
1. Australian Capital Territory Health Human Research
Ethics Committee (ETH 10.10.370).
2. Calvary Hospital Human Research Ethics Committee.
3. University of Queensland Medical Research Ethics
Committee (2010001488).
Any adverse events connected with the trial would be
immediately reported to all three committees above as
well as registered through the hospital risk management
system.
The results of this study will be presented at national
and international intensive care and physiotherapy
conferences and will be submitted for publication in
peer-reviewed journals particularly focused on intensive
care medicine.
DISCUSSION
The ﬁndings of this study would be highly relevant to
intensive care staff who address the challenges of venti-
latory weaning and physical rehabilitation. Any inter-
vention that can hasten weaning from MV, or recovery
following ICU stay, is highly likely to reduce overall
length of stay and may reduce associated morbidity and
mortality. In addition to the individual patient beneﬁts
that this will produce, there is a potential for a substan-
tial community economic beneﬁt due to reduced
hospital costs.
If efﬁcacy of IMTcan be demonstrated, this could lead
to a change in intensive care practice internationally
across disciplines, including physiotherapy, respiratory
therapy, nursing and intensive care medicine. Ultimately,
the people most likely to beneﬁt from this study are the
patients, with improved understanding of methods to
optimise treatment and minimise the complications of
prolonged MV.
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